MENU
SLGL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Sol-Gel Technologies (SLGL) Ownership - Who owns Sol-Gel Technologies?

Sol-Gel Technologies Ltd is a dermatology company... Show more

Profile

Industry
Pharmaceuticals Major
Address
7 Golda Meir Street
Phone
+972 89313429
Employees
36
Web
https://www.sol-gel.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
121.27M
P/E Ratio
N/A
Total Cash
20.84M
Projected Growth
N/A
Total Debt
1.08M
Revenue
18.97M
Risk (Beta)
1.46
Dividend Yield
N/A
Total Cash/Share
7.48
Total Debt/Equity
N/A
Revenue/Share
6.81 USD as % of share price

Fundamentals

SLGL
Capitalization
121M
P/E Ratio
N/A
Risk (Beta)
1.46
Dividend Yield
N/A
Total Cash
20.8M
Total Cash/Share
7.48
Total Debt
1.08M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
6.81%
Revenue
19M
ROE
N/A
Book Value
26M
P/B Ratio
4.66
Cash Flow
N/A
Earnings
-3.23
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
774K
Current Ratio
5.15
Current Revenue Per Employee
11764.71
Dividends Per Share - Security
N/A
EBITDA
-10.23M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-23.17
Shares Held By Institutions
12.1M
Shares Outstanding - Current
2.79M
Total Liabilities
8.56M
Total Volume MTD
N/A
Value
-1
Gain YTD
368.014
View a ticker or compare two or three
SLGL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. SLGL showed earnings on November 20, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a provider of drug delivery solutions

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
7 Golda Meir Street
Phone
+972 89313429
Employees
36
Web
https://www.sol-gel.com